Sensitization of leukemic cells with growth-factor priming ref is a clinically applicable means of enhancing the efficacy of chemotherapy in patients with AML : in vitro, the simultaneous exposure of leukemic cells to chemotherapy and growth factors such as increases the susceptibility of the cells to killing by chemotherapy, especially by the cell-cyclespecific agent cytarabine ref1, ref2.

Related news

Sera que ele vai voltaire pra mim ou
Vila velha restaurante sagres portugal accommodation
Yazarkafe moda health
Your brain on love review cirque
Dr eduardo queiroz miranda
Question permis de conduire 20854
Musqueam first nation chief wages
Crows nest antiques lenoir nc map